Ben Franklin clients US Specialty Formulations, LLC and Vaxform, LLC, Allentown, are developing a new oral COVID-19 vaccine that promises to expand the number of people vaccinated around the world. It does not require refrigeration and is drunk rather than injected, making it especially helpful for administration in developing nations. Via PBS39.
Ben Franklin Technology Partners Announces Over $2 Million in Q4 Investments
Ben Franklin Technology Partners of Northeastern Pennsylvania has approved $2,030,281.00 in investments from April to June of fiscal year 2025. These investments will support 17 companies—11 early-stage companies and six
June 24, 2025
